ClinicaSpace.com
Clinical Research
News & Careers
 
Search the Site
    
 
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login   

By Industry | By Industry Segment | By Services and Suppliers | By Location | Profile Search
 Company Profile

 

Supernus Pharmaceuticals 

1550 East Gude Drive

Rockville  Maryland  20850  U.S.A.
Phone: 301-838-2501 Fax: n/a


SEARCH JOBS



 Key Statistics


Email:
Ownership: Public

Web Site: Supernus Pharmaceuticals
Employees:
Symbol: SUPN
 



Industry
Pharmaceutical






 Company News
Supernus Pharmaceuticals (SUPN) Announces Issuance of Fourth US Patent Protecting Oxtellar XR® 9/4/2014 9:16:05 AM
Supernus Pharmaceuticals (SUPN) Announces Paragraph IV ANDA Filing for Trokendi XR® 8/21/2014 7:54:43 AM
Supernus Pharmaceuticals (SUPN) To Attend FBR Healthcare Conference In September 8/20/2014 7:34:14 AM
Supernus Pharmaceuticals (SUPN) To Attend FBR Healthcare Conference In September 8/19/2014 10:37:29 AM
Supernus Pharmaceuticals (SUPN) Snags FDA Fast Track Designation For ADHD Drug SPN-810 8/14/2014 6:15:11 AM
Supernus Pharmaceuticals (SUPN) Announces Second Quarter 2014 Results 8/11/2014 5:06:56 PM
Supernus Pharmaceuticals (SUPN) To Host Second Quarter 2014 Earnings Conference Call 7/29/2014 10:18:48 AM
Supernus Pharmaceuticals (SUPN) To Receive $30 Million In Non-Dilutive Royalty Deal 7/8/2014 7:22:29 AM
Supernus Pharmaceuticals (SUPN) To Present At Jefferies Healthcare Conference In June 5/22/2014 9:05:30 AM
Supernus Pharmaceuticals (SUPN) Receives $2 Million Milestone For United Therapeutics Corporation (UTHR)' Launch Of Orenitram™ 5/21/2014 9:32:31 AM
1234567